Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 4 | 2023 | 1668 | 0.850 |
Why?
|
| Women | 2 | 2021 | 230 | 0.810 |
Why?
|
| Peripartum Period | 1 | 2022 | 133 | 0.770 |
Why?
|
| Acute Coronary Syndrome | 5 | 2019 | 2337 | 0.770 |
Why?
|
| Contraception | 1 | 2023 | 359 | 0.700 |
Why?
|
| Abortion, Induced | 1 | 2024 | 458 | 0.620 |
Why?
|
| Cardiovascular System | 1 | 2024 | 832 | 0.550 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 161 | 0.540 |
Why?
|
| Platelet Function Tests | 1 | 2017 | 270 | 0.520 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 3068 | 0.510 |
Why?
|
| Physicians, Women | 2 | 2019 | 486 | 0.490 |
Why?
|
| Career Choice | 2 | 2019 | 744 | 0.480 |
Why?
|
| Ticlopidine | 2 | 2017 | 899 | 0.450 |
Why?
|
| Heptanoic Acids | 1 | 2014 | 343 | 0.420 |
Why?
|
| Pravastatin | 1 | 2014 | 395 | 0.410 |
Why?
|
| Communication Barriers | 1 | 2014 | 398 | 0.400 |
Why?
|
| Adenosine | 1 | 2015 | 825 | 0.370 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2586 | 0.360 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 1913 | 0.360 |
Why?
|
| Angina, Unstable | 1 | 2014 | 926 | 0.360 |
Why?
|
| Pregnancy | 13 | 2024 | 29142 | 0.340 |
Why?
|
| Heparin | 1 | 2015 | 1637 | 0.320 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 850 | 0.310 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 502 | 0.310 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 11728 | 0.310 |
Why?
|
| Pyrroles | 1 | 2014 | 1143 | 0.300 |
Why?
|
| Pre-Eclampsia | 3 | 2024 | 1200 | 0.290 |
Why?
|
| Blood Platelets | 1 | 2017 | 2508 | 0.270 |
Why?
|
| Heart Failure | 5 | 2023 | 10905 | 0.260 |
Why?
|
| Societies, Medical | 1 | 2017 | 3741 | 0.250 |
Why?
|
| Aspirin | 1 | 2016 | 3282 | 0.250 |
Why?
|
| Ventricular Remodeling | 2 | 2023 | 1224 | 0.240 |
Why?
|
| Hemorrhage | 1 | 2015 | 3461 | 0.230 |
Why?
|
| Stroke Volume | 3 | 2023 | 5008 | 0.230 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1971 | 0.200 |
Why?
|
| Family Planning Services | 1 | 2023 | 263 | 0.190 |
Why?
|
| Anticoagulants | 1 | 2015 | 4599 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6489 | 0.180 |
Why?
|
| Radiation Protection | 1 | 2023 | 419 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.170 |
Why?
|
| Menopause, Premature | 1 | 2020 | 132 | 0.170 |
Why?
|
| Live Birth | 1 | 2023 | 512 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3256 | 0.170 |
Why?
|
| Female | 22 | 2024 | 380197 | 0.160 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 489 | 0.160 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 853 | 0.160 |
Why?
|
| Personnel Selection | 1 | 2019 | 189 | 0.150 |
Why?
|
| Career Mobility | 1 | 2019 | 262 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5034 | 0.140 |
Why?
|
| Echocardiography, Stress | 1 | 2017 | 131 | 0.140 |
Why?
|
| Humans | 26 | 2024 | 744220 | 0.140 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 840 | 0.130 |
Why?
|
| Counseling | 1 | 2023 | 1523 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 579 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5709 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 1573 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 800 | 0.110 |
Why?
|
| Job Satisfaction | 1 | 2017 | 535 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 15161 | 0.110 |
Why?
|
| Menopause | 1 | 2020 | 1626 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 851 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 686 | 0.100 |
Why?
|
| Patient Participation | 1 | 2021 | 1457 | 0.100 |
Why?
|
| Neurons | 1 | 2010 | 9335 | 0.100 |
Why?
|
| Heart Ventricles | 2 | 2020 | 3820 | 0.100 |
Why?
|
| Aorta | 1 | 2018 | 2061 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2010 | 322 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3669 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1531 | 0.090 |
Why?
|
| Premature Birth | 1 | 2022 | 1721 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 246 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1127 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2016 | 1167 | 0.080 |
Why?
|
| Creatinine | 1 | 2014 | 1919 | 0.080 |
Why?
|
| Sex Factors | 3 | 2018 | 10396 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1181 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2015 | 3913 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4929 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7908 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2726 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 1701 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2022 | 21752 | 0.060 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2024 | 70 | 0.060 |
Why?
|
| Male | 9 | 2021 | 350027 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1670 | 0.060 |
Why?
|
| Risk Factors | 2 | 2023 | 72280 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1838 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29050 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6367 | 0.050 |
Why?
|
| Parental Leave | 1 | 2022 | 79 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15525 | 0.050 |
Why?
|
| Middle Aged | 6 | 2023 | 213367 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12035 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 20945 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 264 | 0.040 |
Why?
|
| Laboratories | 1 | 2023 | 463 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9735 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11732 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15538 | 0.040 |
Why?
|
| Catheterization | 1 | 2023 | 1469 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4465 | 0.040 |
Why?
|
| Obesity | 1 | 2018 | 12742 | 0.030 |
Why?
|
| United States | 3 | 2022 | 69867 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Rats | 1 | 2010 | 24273 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 964 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 18367 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77426 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 214035 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11478 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12264 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1132 | 0.030 |
Why?
|
| Leadership | 1 | 2021 | 1357 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 1814 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 2796 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2453 | 0.020 |
Why?
|
| Life Style | 1 | 2022 | 3835 | 0.020 |
Why?
|
| Cholesterol | 1 | 2018 | 2911 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2018 | 1921 | 0.020 |
Why?
|
| Troponin T | 1 | 2013 | 753 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
| Animals | 2 | 2021 | 168788 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3863 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2018 | 6259 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12355 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 81178 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2715 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 25618 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12718 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 163253 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_